155
Views
3
CrossRef citations to date
0
Altmetric
Malignancy

Epidemiology of Multiple Myeloma

&
Pages 1-15 | Received 19 Feb 1998, Published online: 13 Jul 2016

References

  • Davis, D. L., Hoel, D. G., Fox, J. and Lopex, A. D. (1990). International trends in cancer mortality in France, West Germany, Italy, Japan, England and Wales and the United States. Ann. N.Y. Acad. Sci., 609, 5–48.
  • Alexander, F. E., Ricketts, T. J., McKinney, P. A. and Cartwright, R. A. (1989). Cancer registration of leukaemias and lymphomas: results of a comparison with a specialist registry. Comm. Med., 11, 81–89.
  • Cartwright, R. A., McNally, R. J. Q., Rowland, D. J. and Thomas, J. (1997). The descriptive epidemiology of leukaemia and related conditions in parts of the United Kingdom 1984–1993. Leukaemia Research Fund.
  • Parkin, D. M., Muir, C. S., Whelan, S. L., Gao, Y. T., Ferlay, J. and Powell, J. (1992). Cancer Incidence in Five Continents, Volume VI. Lyon: IARC.
  • Schulman, G. and Jacobson, R. J. (1980). Immunocytoma in black and white South Africans. Trop. Geog. Med., 32, 112–117.
  • Blattner, W. H., Jacobson, R. J. and Schulman, G. (1979). Multiple myeloma in South African Blacks. Lancet, i, 928–929.
  • Shapiro, R. and Carter, A. (1986). Multiple myeloma in North Israel 1970–79. Cancer, 58, 206–209.
  • Kanoh, T., Ohno, T., Usui, T. and Inamoto, Y. (1989). Multiple myeloma in husband and wife. Acta. Haematol. Japonica, 52, 763–766.
  • Kyle, R. A. and Greipp, P. R. (1983). Multiple myeloma—Houses and spouses. Cancer, 51, 735–739.
  • Brugiatelli, M., Comis, M., Lacopino, P., Morabito, F., Nobile, F., Lombardo, V. T. and Neri, A. (1980). Multiple myeloma in husband and wife. Acta. Haematol., 64, 227–229.
  • Kyle, R. A., Heath, C. W. and Carbone, P. (1971). Multiple myeloma in spouses. Arch. Internal. Med., 127, 944–946.
  • Kanoh, T. (1988). Multiple myeloma in spouses. Eur. J. Haematol., 41, 397.
  • Pietruszka, M., Rabin, B. S. and Srodes, C. (1976). Multiple myeloma in husband and wife. Lancet, i, 314.
  • Kyle, R. A., Herber, L., Evatt, B. L. and Heath, C. W. (1970). Multiple myeloma: community cluster. JAMA, 213, 1339–1341.
  • Kyle, R. A., Finkelstein, S., Elveback, L. R. and Kurland, L. T. (1972). Incidence of monoclonal proteins in a Minnesota community with a cluster of multiple myeloma. Blood, 40, 719–724.
  • Ende, M. (1979). Multiple myeloma: a cluster in Virginia. Virginia Med., 106, 115–116.
  • Kosaka, M., Okagaw, K., Miyamoto, Y., Goto, T. and Saito, S. (1991). Geographic clustering of myeloma in Tokushima. Int. J. Haematol., 54, 405–409.
  • Cartwright, R. A., Alexander, F. E., McKinney, P. A. and Ricketts, T. J. (1990). Leukaemia and lymphoma: An atlas of distribution within areas of England and Wales 1984–1988. Leukaemia Research Fund.
  • Coleman, M. P., Esteve, J., Damiecki, P., Arslan, A. and Renard, H. (1993). Trends in Cancer Incidence and Mortality. IARC Scientific Publication 121, WHO, Lyon.
  • Zheng, T., Mayne, S. T. and Flannery, J. (1992). The time trends of multiple myeloma in Connecticut, 1935–1987. Internat. J. Cancer, 50, 163–164.
  • Hoover, R. N., Mason, T. J., McKay, F. W. and Fraumeni, J. F. (1975). Geographical pattern of cancer mortality in the U.S. In Fraumeni JF(Ed.).
  • Velez, R., Beral, V. and Cuzick, J. (1982). Increasing trends of multiple myeloma mortality in England and Wales, 1950–1979. Are the changes real? JNCI, 69, 387–92.
  • Johnston, J. M., Grufferman, S., Bourguet, C., Delzell, E., Delory, E. and Cohen, H. (1985). Socio-economic status and risk of multiple myeloma. J. Epidemiol. Comm. Health, 39, 175–178.
  • Axelsson, U., Backmann, R. and Hällén, J. (1966). Frequency of pathological protein (M-components) in 6995 sera from an adult population. Act. Med. Scand., 179, 235–247.
  • Saleun, J., Vicariot, M., Deroff, P. and Morin, J. (1982). Monoclonal gammopathies in the adult population of Finistére. J. Clin. Pathol., 35, 63–68.
  • Axelsson, U. (1986). A 20 year follow up study of 64 subjects with M-components. Acta. Med. Scand., 219, 519–522.
  • Kyle, R. (1993). ‘Benign’ monoclonal gammopathy after 20 to 35 years of follow up. Mayo Clin. Proc., 68, 26–36.
  • Blade, J., Lopez-Guillerno, A., Rozman, C. and Carvantes, F. (1992). Malignant transformation and life expectancy in monoclonal gammopathy of undetermined significance. Br. J. Haematol., 81, 391–394.
  • Schechter, G. P., Slott, N., Chan, C., McMairs, C. D. and Hawley, H. P. (1991). The frequency of MGUS in black and Caucasian veterans. In: Epidemiology and Biology of Multiple Myeloma, edited by Obrams G.I. and Potter, M. pp.83–85. NY: Springer-Verlag.
  • Herrington, L. J., Demen, P. A., Kepsell, D. and Weiss, N. S. (1993). Epidemiology of the M-component immunoglobulin types of multiple myeloma. Cancer Cause and Control, 4, 83–92.
  • Nishiyama, H., Anderson, R. E., Ishimaru, T., Ishida, K., Li, Y. and Okabe, N. (1973). The incidence of malignant lymphoma and multiple myeloma in Hiroshima and Nagasaki atomic bomb survivors, 1945–1965. Cancer, 32, 1301–1309.
  • Ishimaru, T. and Finch, S. C. (1979). More on radiation exposure and multiple myeloma. New Eng. J. Med., 301, 439–440.
  • Ichimaru, M., Ishimaru, T., Mikami, M. and Matsunaga, M. (1982). Multiple myeloma amongst atomic bomb survivors 1950–1976. JNCI, 69, 323–8.
  • Ichimaru, M. and Mabuchi, K. (1991). Multiple myeloma atom bomb survivors. J. Rad. Res. Suppl., 168–171.
  • Preston, D., Kusumi, S., Tomonaga, M., Izumi, S., Ron, E., Kuramoto, A. and Kamada, N. (1994). Cancer incidence in atomic bomb survivors part III, Leukaemia, lymphomas and multiple myeloma 1950–1987. Rad. Res., 137, 568–597.
  • Pierce, R., Shimizu, Y., Preston, D., Vaeth, M. and Mabuchi, K. (1996). Studies of the mortality of Atom bomb survivors, Report 12, Part I. Cancer 1950–1990. Rad. Res., 146, 1–27.
  • Lewis, E. B. (1963). Leukaemia, multiple myeloma and aplastic anaemia in American radiologists. Science, 42, 1492–1494.
  • Mancuso, T. F., Stewart, A. and Kneale, G. (1977). Radiation exposures of Hanford workers dying from cancer and other causes. Health Physics, 33, 369–385.
  • Gilbert, E. S. and Marks, S. (1979). An analysis of mortality of workers in a nuclear facility. Rad. Res., 79, 122–148.
  • Polednak, A. P., Stehney, A. F. and Rowland, R. E. (1978). Mortality among women first employed before 1930 in the US radium dial painting industry. Am. J. Epidemiol., 107, 179–195.
  • Cardis, E., Gilbert, E. S. and 15 others. (1995). Effects of low doses and low dose rates of external ionising irradiation: cancer mortality among nuclear industry workers in 3 countries. Rad. Res., 142, 117–132.
  • Darby, S., Kendall, G., Fell, T., O'Hagan, J., Muirhead, C., Ennis, J. Ball, A., Dennis, J. and Doll, R. (1988). A summary of mortality and incidence of cancer in men from the UK who participated in the UK atmospheric nuclear weapons tests and experimental programmes. BMJ, 296, 332–338.
  • Cuzick, J. (1981). Radiation-induced myelomatosis. New Eng. J. Med., 304, 204–210.
  • Andersson, M., Carstensen, B. and Visfeld, J. (1993). Leukaemia and other arelated haematogenous disorders among Danish patients exposed to Thorotrast. Rad. Res., 134, 224–233.
  • Andersson, M., Carstensen, B. and Storm, H. (1995). Mortality and cancer incidence after cerebral areteriography with or without Thorotrast. Rad. Res., 142, 305–320.
  • Davis, F., Boice, J., Hrubec, Z. and Monson, R. (1989). Cancer mortality in a radiation exposed cohort of Massachusetts tuberculosis patients. Cancer Res., 49, 6130–6136.
  • Holm, L., Hall, P., Wiklund, K. and Lindell, G. (1991). Cancer risk after Iodine-131 therapy for hyperthyroidism. JNCI, 83, 1072–1077.
  • Inskip, P., Kleinerman, R., Stovall, M., Coockfair, D. and Hadjimichael, O., Leukaemia, lymphoma and multiple myeloma after pelvic radiotherapy for benign disease. Rad. Res., 135, 108–124.
  • Griem, M., Kleinerman, R., Boice, J., Stovall, M., Shefner, D. and Lubin, J. (1994). Cancer following radiotherapy for peptic ulcer. JNCI, 86, 842–849.
  • Damber, L., Larsson, L., Johansson, L. and Norin, T. (1995). A cohort study with regard to the risk of haematological malignancies in patients treated with x-rays for benign lesion in the locomotor system. I: Epidemiological analyses. Acta. Oncol., 34, 713–719.
  • Darby, S. C., Doll, R., Gill, S. K. and Smith, P. G. (1987). Long term mortality after a single treatment course with x-rays in patients treated for ankylising spondylitis. Br. J. Cancer, 55, 179–190.
  • Boice, J., Engholm, G., Kleinerman, R., Blettner, M. and 39 others. (1988). Radiation dose and second cancer risk in patients treated for cancer of the cervix. Rad. Res., 116, 3–55.
  • Berkheiser, S. W. (1986). Review of leukemia, lymphoma and myeloma before and after the TNI accident. Pennsylvania Med., 89, 50–52.
  • Boice, J. D., Morin, M. M., Glass, A. G., Friedman, G. D., Stovall, M., Hoover, R. N. and Fraumeni, J. F. (1991). Diagnostic x-ray procedures and risk of leukaemia, lymphoma and multiple myeloma. JAMA, 265, 1290–1294.
  • Guralnick, L. (1963). Mortality by occupational level and cause of death among men 20–40 years of age in the United States, 1950. Vital Statistics Special Reports, 53, 480–481.
  • Milham, S. (1971). Leukaemia and multiple myeloma in farmers. Am. J. Epidemiol., 94, 307–310.
  • Gallagher, R. P., Spinelli, J., Elwood, I. and Skippen, D. (1983). Allergies and agricultural exposure as a risk factor for multiple myeloma. Br. J. Cancer, 48, 853–857.
  • Pearce, N., Smith, A. and Fisher, D. O. (1985). Malignant lymphoma and multiple myeloma linked with agricultural occupations in a New Zealand cancer registry-based study. Am. J. Epidemiol., 121, 225–237.
  • Steineck, G. and Wiklund, K. (1986). Multiple myeloma in Swedish agricultural workers. Int. J. Epidemiol., 15, 321–325.
  • Pearce, N., Smith, A., Howard, J., Sheppard, R., Giles, H. and Teague, C. (1986). Case control study of multiple myeloma and farming. Br. J. Cancer, 54, 493–500.
  • McLaughlin, J., Linet, M., Stone, B., Blot, W., Fraumeni, J., Malker, H. S. R., Weiner, J. A. and Ericsson, J. L. E. (1988). Multiple myeloma and occupation in Sweden. Arch. Env. Health, 43, 7–10.
  • Cuzick, J. and de Stavola, B. (1988). Multiple Myeloma: A case control study. Br. J. Cancer, 57, 516–520.
  • Boffetta, P., Stellman, S. D. and Garfinkel, L. (1989). A case-control study of multiple myeloma nested in the American Cancer Society prospective study. Int. J. Cancer, 43, 554–559.
  • Eriksson, M. and Karlsson, M. (1992). Occupational and other environmental factors and multiple myeloma: a population based case-control study. Br. J. Ind. Med., 49, 95–103.
  • Demers, P., Vaughan, T., Koepsell, T. and Lyon, J. (1993). A case-control study of multiple myeloma and occupation. Am. J. Ind. Med., 23, 629–639.
  • Brown, L., Burmeister, L., Everett, G. and Blair, A. (1993). Pesticide exposure and multiple myeloma in Iowa men. Cancer Causes and Control, 4, 153–156.
  • Nandakumar, A., Armstrong, B. K. and De Klerk, N. H. (1986). Multiple myeloma in Western Australia: a case-control study in relation to occupation, father's occupation, socio-economic status and country of birth. Int. J. Cancer, 37, 223–226.
  • Brownson, R. and Reif, J. (1988). A cancer registry-based study of occupational risk for lymphoma, multiple myeloma and leukaemia. Int. J. Epidemiol., 17, 27–32.
  • Williams, A., Weis, R., Koepsell, T., Lyon, J. and Swanson, G. (1989). Infectious and non-infectious exposure in the etiology of light chain myeloma: a case control study. Cancer Res., 49, 4038–4041.
  • Heineman, E., Olsen, J., Pottern, L., Gomez, M., Raffn, E. and Blair, A. (1992). Occupational risk factors for multiple myeloma among Danish men. Cancer Causes and Control, 3, 555–568.
  • Pottern, L., Heineman, E., Olsen, J. and Raffn, E. (1992). Multiple myeloma among Danish women: employment history and workplace exposure. Cancer Causes and Control, 3, 427–432.
  • Saracci, R., Kogevinas, M., Bertazzi, P. A., Bueno de Mesquita, B. H., Kaupponen, T., L'Abbe, K. A., Littorin, M., Lynge, E., Mathews, J. D., Neiberger, M., Osman, J., Pearce, N. and Winkelmann, R. (1991). Cancer mortality in workers exposed to chlorophenoxy herbicides and chlorophenols. Lancet, 338, 1027–1032.
  • Bertazzi, P., Pesatori, A., Consonni, D. and Tironi, A. (1993). Cancer incidence in a population accidentally exposed to 2,3, 7, 8-Tetrachlorodibenzo-para-dioxin. Epidemiology, 4, 398–406.
  • Kagan, E., Jacobson, R., Yeung, K., Haidak, D. and Nachnani, G. (1979). Asbestos associated neoplasm of B-cell lineage. Am. J. Med., 67, 325–330.
  • Schwartz, D., Vaughn, T., Heger, N., Koepsell, D., Logan, J., Swanson, M. and Weiss, N. (1988). B-cell neoplasm and occupational asbestos exposure. Am. J. Ind. Med., 14, 661–671.
  • Linet, M., Stewart, W. F., Van Natta, M. L., McCaffrey, L. D. and Szklo, M. (1987). Comparison of methods for determining occupational exposure in a case-control interview study of chronic lymphocytic leukaemia. J. Occupational Med., 29, 136–141.
  • Eriksson, M. and Karlsson, M. (1992). Occupational and other environmental factors and multiple myeloma: a population based case-control study. Br. J. Ind. Med., 49, 95–103.
  • Bross, I., Viadana, E. and Houten, L. (1978). Occupational cancer in men exposed to dust and other environmental hazards. Arch. Env. Health, 33, 300–307.
  • Berg, J. and Burbank, F. (1972). Correlation between carcinogenic trace metals in water supplies and cancer mortality. Ann. New York Acad. Science, 199, 249–264.
  • Egedahl, R., Carpenter, M. and Homik, R. (1993). An update of an epidemiological study at a hydrometallurgical Nickel refinery in Fort Saskatchewan, Alberta. Statistics Canada, Health Reports, 5, 291–302.
  • Monson, R. and Nakano, K. (1976). Mortality among rubber workers: II. Other employees. Am. J. Epidemiol., 103, 297–303.
  • Andjelkovich, D., Taulbee, J. and Blum, S. (1978). Mortality of female workers in a rubber manufacturing plant. J. Occ. Med., 20, 409–413.
  • Namboodiri, K. K. and Harris, R. E. (1991). Haematopoietic and lymphoproliferative cancer among male veterans using the veteran administration medical system. Cancer, 68, 1123–1130.
  • Figgs, L., Dosemeci, M. and Blair, A. (1994). Risk of multiple myeloma by occupation and industry among men and women: a 24 state death certificate study. J. Occ. Med., 36, 1210–1221.
  • Grufferman, S., Cohen, H., Delzell, E., Morrison, M. C., Schold, C. and Moore, J. O. (1989). Familial aggregation of multiple myeloma and central nervous system diseases. J. Am. Gen. Soc., 37, 303–309.
  • Eriksson, M. and Hallberg, B. (1992). Familial occurrence of hematologic malignancies and other disease in multiple myeloma: A case-control study. Cancer Causes and Control, 3, 63–67.
  • Allan, T. M. (1970). ABO blood groups and myelomatosis. BMJ, 4, 178.
  • Fester, J., Marrink, J. and Sijpesteijn, J. (1976). A study on the association between myelomatosis and immunoglobulin all types, HLA, and blood groups. Immunogen., 3, 201.
  • Ludwig, H. and Mayr, W. (1982). Genetic aspects of susceptibility to multiple myeloma. Blood, 59, 1286–1291.
  • Pottern, L. M., Gart, J., Nam, J.-M. and Dunston, G. (1992). HLA and multiple myeloma among black and white men: evidence of a genetic association. Cancer Epidemiology, Biomarkers and Prevention, 1, 177–182.
  • Wegelius, O., Skrifvars, B. and Andersson, L. (1970). Rheumatoid Arthritis terminating in plasmacytoma. Acta. Med. Scand., 187, 133–138.
  • Goldenberg, G., Paraskevas, F. and Israels, L. G. (1969). The association of rheumatoid arthritis with plasma cell and lymphocytic neoplasm. Arthritis and Rheumatism, 12, 569–579.
  • Isomaki, H., Hakulinen, T. and Jousenlahti, U. (1978). Excess risk of lymphomas, leukaemia and myeloma in patients with rheumatoid arthritis. J. Chron. Dis., 31, 691–696.
  • Eriksson, M. (1993). Rheumatoid arthritis as a risk factor for multiple myeloma: a case-control study. Eur. J. Cancer, 29, 259–263.
  • Gramenzi, A., Buttino, I. and D'Avanzo, B. (1991). Medical history and the risk of multiple myeloma. Br. J. Cancer, 63, 769–772.
  • Doody, M., Linet, M., Glass, A. and Friedman, G. (1992). Leukaemia, lymphoma and multiple myeloma following selected medical conditions. Cancer Causes and Control, 3, 449–456.
  • Lewis, D. R., Brown, L. M., Sliverman, D. T., Hayes, R. B., Schoenberg, J. B., Greenberg, R. S., Swanson, G. M., Schwartz, A. G., Liff, J. M. and Hoover, R. N. (1994). Multiple myeloma among blacks and whites in the United States: the role of chronic antigenic stimulation. Cancer Causes and Control, 5, 529–539.
  • Gallagher, R. P., Spinelli, J., Elwood, I. and Skippen, D. (1983). Allergies and agricultural exposure as a risk factor for multiple myeloma. Br. J. Cancer, 48, 853–857.
  • Koepsell, T., Daling, J. and Weiss, N. (1987). Antigenic stimulation and the occurrence of multiple myeloma. Am. J. Epidemiol., 126, 1051–1061.
  • Cohen, H. J., Bernstein, R. J. and Grufferman, S. (1987). Role of immune stimulation in the etiology of multiple myeloma: a case-control study. Am. J. Hematol., 24, 119–126.
  • Brown, J., Newstead, C., Lucas, G. and Johnson, R. (1992). Multiple myeloma in a renal transplant patient. Nephro Dial Transplant, 7, 447–479.
  • Thomas, M. A. B., Isbister, J. P., Ibels, L. S., Cooper, D. A., Wells, J. V. and McMahon, C. (1986). IgA Kappa. Multiple myeloma and lymphadenopathy syndrome associated with AIDS virus infection. Aus. N. Z. J. Med., 16, 402–404.
  • Karnad, A. and Wright, J. (1987). Neoplastic complications of Human Immunodeficiency Virus infection. Am. J. Med., 82, 1282.
  • IARC. (1996). Monograph of the evaluation of carcinogenic risks to humans. Vol 67. Human Immunodeficiency Viruses and human T-cell lymphadenopathy viruses. IARC, Lyon, France.
  • Henry, J. W. (1979). Multiple myeloma in a mink handler following exposure to Aleutian disease. Cancer, 44, 273–275.
  • Brown, L. M., Everett, G. D., Gibson, R., Burmeister, L. F., Schuman, L. M. and Blair, A. (1992). Smoking and risk of non-Hodgkin's lymphoma and multiple myeloma. Cancer Causes and Control, 3, 49–55.
  • Heineman, E. F., Zahm, S. H., McLaughlin, J. K., Vaught, J. B. and Hrubec, Z. (1992). A prospective study of tobacco use and multiple myeloma: evidence against an association. Cancer Causes and Control, 3, 31–36.
  • Friedman, G. (1993). Cigarette smokers, leukaemia and multiple myeloma. Ann. Epidemiol., 3, 425–428.
  • Mills, P. D., Newell, G. R., Beeson, W. L., Fraser, G. E. and Phillips, R. L. (1990). History of cigarette smoking and risk of leukaemia and myeloma: results from the Adventist Health study. JNCI, 82, 1832–1836.
  • Brown, L., Gibson, R., Burmeister, L., Schuman, L., Everett, G. and Blair, A. (1992). Alcohol consumption and the risk of leukaemia, non-Hodgkin's lymphoma and multiple myeloma. Leuk. Res., 16, 979–984.
  • Guidotti, S., Wright, W. and Peters, J. (1982). Multiple myeloma in cosmetologists. Am. J. Ind. Med., 3, 169–171.
  • Zahm, S., Weisenburger, D., Babbitt, P., Saal, R., Vaught, J. and Blair, A. (1992). Use of hair colouring products and the risk of lymphoma, multiple myeloma and chronic lymphocytic leukaemia. Am. J. Public Health, 82, 990–997.
  • Grodstein, F., Hennekens, H., Colditz, G., Hunter, D. and Stampfer, M. (1994). A prospective study of permanent hair dye use and hemopoietic cancer. JNCI, 86, 1466–1470.
  • Cartwright, R. A. and McNally, R. J. Q. (1994). Epidemiology of non-Hodgkin's lymphoma. In: Haematological Oncology, Edited by Burnett, A. Armitage, J. Newland A. and Keating A., Vol 3, pp 1–34. Cambridge University Press.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.